Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gadopentetate dimeglumine 469.01mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
acide gadopentétique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
1 |
Dimeglumine gadopentetate enteral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 5 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 10 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 15 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 15 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection solution 20 mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 469.01mg/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|
Dimeglumine gadopentetate 1.876mg/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gadopentetate dimeglumine |
Inferred relationship |
Some |
|